These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 16882998)

  • 1. 18F-FDG PET after radiofrequency ablation: Is timing everything?
    Avril N
    J Nucl Med; 2006 Aug; 47(8):1235-7. PubMed ID: 16882998
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of whole-body imaging on treatment decision to radio-frequency ablation in patients with malignant liver tumors: comparison of [18F]fluorodeoxyglucose-PET/computed tomography, PET and computed tomography.
    Kuehl H; Rosenbaum-Krumme S; Veit-Haibach P; Stergar H; Forsting M; Bockisch A; Antoch G
    Nucl Med Commun; 2008 Jul; 29(7):599-606. PubMed ID: 18528181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How do we best balance optimal timing of FDG PET-CT imaging?
    Hofman MS; O'Doherty M
    Nucl Med Commun; 2007 Dec; 28(12):885-7. PubMed ID: 18090212
    [No Abstract]   [Full Text] [Related]  

  • 4. Utility of 18F-FDG-PET/CT imaging in the diagnosis of appendicitis.
    Moghadam-Kia S; Nawaz A; Newberg A; Basu S; Alavi A; Torigian DA
    Hell J Nucl Med; 2009; 12(3):281-2. PubMed ID: 19936346
    [No Abstract]   [Full Text] [Related]  

  • 5. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
    Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Considerations for generic oncology FDG-PET/CT protocol preparation in drug development.
    Hallett WA; Maguire RP; McCarthy TJ; Schmidt ME; Young H
    IDrugs; 2007 Nov; 10(11):791-6. PubMed ID: 17968761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18F-FDG-PET/CT as an indicator for resection of pulmonary epithelioid hemangioendothelioma.
    Watanabe S; Yano F; Kita T; Soga S; Shinmoto H; Kosuda S; Ozeki Y; Aida S; Sakata I
    Ann Nucl Med; 2008 Jul; 22(6):521-4. PubMed ID: 18670859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and localization of renal cyst infection by 18F-fluorodeoxyglucose PET/CT in polycystic kidney disease.
    Soussan M; Sberro R; Wartski M; Fakhouri F; Pecking AP; Alberini JL
    Ann Nucl Med; 2008 Jul; 22(6):529-31. PubMed ID: 18670861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomography-computerized tomography findings in a urinary bladder paraganglioma.
    Thambugala GM; Fulham MJ; Mohamed A
    Australas Radiol; 2007 Oct; 51 Spec No.():B45-7. PubMed ID: 17875156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prosthetic vascular graft infection: the role of 18F-FDG PET/CT.
    Keidar Z; Engel A; Hoffman A; Israel O; Nitecki S
    J Nucl Med; 2007 Aug; 48(8):1230-6. PubMed ID: 17631553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic sequelae of herpes simplex encephalitis demonstrated on interictal F-18 FDG PET/CT.
    Wong KK; Tolia B; Bohnen N
    Clin Nucl Med; 2008 Jun; 33(6):443-4. PubMed ID: 18496462
    [No Abstract]   [Full Text] [Related]  

  • 12. Focal bone marrow involvement in multicentric castleman disease demonstrated by FDG PET/CT.
    Ramos CD; Massumoto CM; Rosa MF; Mazo-Ruiz MF; Mitteldorf C; Etchebehere EC; Santos AO; Lima MC; Cerri GG; Camargo EE
    Clin Nucl Med; 2007 Apr; 32(4):295-6. PubMed ID: 17413577
    [No Abstract]   [Full Text] [Related]  

  • 13. FDG-PET CT for tumor imaging.
    Miller JC; Fischman AJ; Aquino SL; Blake MA; Thrall JH; Lee SI
    J Am Coll Radiol; 2007 Apr; 4(4):256-9. PubMed ID: 17412280
    [No Abstract]   [Full Text] [Related]  

  • 14. FDG PET/CT imaging of a gastric fistula.
    Strobel K; Zippelius A; Hany TF
    Clin Nucl Med; 2007 Apr; 32(4):336-7. PubMed ID: 17413593
    [No Abstract]   [Full Text] [Related]  

  • 15. A unique presentation of appendicitis: F-18 FDG PET/CT.
    Koff SG; Sterbis JR; Davison JM; Montilla-Soler JL
    Clin Nucl Med; 2006 Nov; 31(11):704-6. PubMed ID: 17053390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDG PET and PET/CT monitoring of autoimmune pancreatitis associated with extrapancreatic autoimmune disease.
    Nakajo M; Jinnouchi S; Noguchi M; Uozumi K; Tanabe H; Tateno R; Nakajo M
    Clin Nucl Med; 2007 Apr; 32(4):282-5. PubMed ID: 17413574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of histologically proven peritoneal carcinomatosis with fused 18F-FDG-PET/MDCT.
    Dirisamer A; Schima W; Heinisch M; Weber M; Lehner HP; Haller J; Langsteger W
    Eur J Radiol; 2009 Mar; 69(3):536-41. PubMed ID: 18248928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positron emission tomography/computed tomography: the current technology and applications.
    Mittra E; Quon A
    Radiol Clin North Am; 2009 Jan; 47(1):147-60. PubMed ID: 19195540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Splenic infarction mimicking a necrotizing metastasis of malignant melanoma on F-18 FDG PET/CT.
    Ahmadzadehfar H; Brockmann H; Schmiedel A; Biersack HJ; Ezziddin S
    Clin Nucl Med; 2008 Aug; 33(8):571-2. PubMed ID: 18645383
    [No Abstract]   [Full Text] [Related]  

  • 20. Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer.
    De Giorgi U; Valero V; Rohren E; Dawood S; Ueno NT; Miller MC; Doyle GV; Jackson S; Andreopoulou E; Handy BC; Reuben JM; Fritsche HA; Macapinlac HA; Hortobagyi GN; Cristofanilli M
    J Clin Oncol; 2009 Jul; 27(20):3303-11. PubMed ID: 19451443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.